Endoluminal contrast for abdomen and pelvis magnetic resonance imaging

Mohit K. Gupta, Gaurav Khatri, April Bailey, Daniella F. Pinho, Daniel Costa, Ivan Pedrosa

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Magnetic resonance (MR) imaging of the abdomen and pelvis can be limited for assessment of different conditions when imaging inadequately distended hollow organs. Endoluminal contrast agents may provide improved anatomic definition and detection of subtle pathology in such scenarios. The available routes of administration for endoluminal contrast agents include oral, endorectal, endovaginal, intravesicular, and through non-physiologic accesses. Appropriate use of endoluminal contrast agents requires a thorough understanding of the clinical indications, available contrast agents, patient preparation, and interaction of the contrast agent with the desired MR imaging protocol. For example, biphasic oral enteric contrast agents are preferred in MR enterography as their signal properties on T1- and T2-weighted imaging allow for evaluation of both intraluminal and bowel wall pathology. In specific situations such as with MR enterography, MR defecography, and accurate local staging of certain pelvic tumors, the use of an endoluminal contrast agent is imperative in providing adequate diagnostic imaging. In other clinical scenarios, the use of an endoluminal contrast agent may serve as an indispensable problem-solving tool.

Original languageEnglish (US)
Pages (from-to)1378-1398
Number of pages21
JournalAbdominal Radiology
Volume41
Issue number7
DOIs
StatePublished - Jul 1 2016

Fingerprint

Pelvis
Abdomen
Contrast Media
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Defecography
Pathology
Diagnostic Imaging
Neoplasms

Keywords

  • Endoluminal contrast
  • GI imaging
  • GU imaging
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology
  • Urology
  • Radiological and Ultrasound Technology

Cite this

Endoluminal contrast for abdomen and pelvis magnetic resonance imaging. / Gupta, Mohit K.; Khatri, Gaurav; Bailey, April; Pinho, Daniella F.; Costa, Daniel; Pedrosa, Ivan.

In: Abdominal Radiology, Vol. 41, No. 7, 01.07.2016, p. 1378-1398.

Research output: Contribution to journalReview article

@article{db8738ccfc4f44fb8a61023b9516497e,
title = "Endoluminal contrast for abdomen and pelvis magnetic resonance imaging",
abstract = "Magnetic resonance (MR) imaging of the abdomen and pelvis can be limited for assessment of different conditions when imaging inadequately distended hollow organs. Endoluminal contrast agents may provide improved anatomic definition and detection of subtle pathology in such scenarios. The available routes of administration for endoluminal contrast agents include oral, endorectal, endovaginal, intravesicular, and through non-physiologic accesses. Appropriate use of endoluminal contrast agents requires a thorough understanding of the clinical indications, available contrast agents, patient preparation, and interaction of the contrast agent with the desired MR imaging protocol. For example, biphasic oral enteric contrast agents are preferred in MR enterography as their signal properties on T1- and T2-weighted imaging allow for evaluation of both intraluminal and bowel wall pathology. In specific situations such as with MR enterography, MR defecography, and accurate local staging of certain pelvic tumors, the use of an endoluminal contrast agent is imperative in providing adequate diagnostic imaging. In other clinical scenarios, the use of an endoluminal contrast agent may serve as an indispensable problem-solving tool.",
keywords = "Endoluminal contrast, GI imaging, GU imaging, Magnetic resonance imaging",
author = "Gupta, {Mohit K.} and Gaurav Khatri and April Bailey and Pinho, {Daniella F.} and Daniel Costa and Ivan Pedrosa",
year = "2016",
month = "7",
day = "1",
doi = "10.1007/s00261-016-0668-0",
language = "English (US)",
volume = "41",
pages = "1378--1398",
journal = "Abdominal Radiology",
issn = "2366-004X",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - Endoluminal contrast for abdomen and pelvis magnetic resonance imaging

AU - Gupta, Mohit K.

AU - Khatri, Gaurav

AU - Bailey, April

AU - Pinho, Daniella F.

AU - Costa, Daniel

AU - Pedrosa, Ivan

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Magnetic resonance (MR) imaging of the abdomen and pelvis can be limited for assessment of different conditions when imaging inadequately distended hollow organs. Endoluminal contrast agents may provide improved anatomic definition and detection of subtle pathology in such scenarios. The available routes of administration for endoluminal contrast agents include oral, endorectal, endovaginal, intravesicular, and through non-physiologic accesses. Appropriate use of endoluminal contrast agents requires a thorough understanding of the clinical indications, available contrast agents, patient preparation, and interaction of the contrast agent with the desired MR imaging protocol. For example, biphasic oral enteric contrast agents are preferred in MR enterography as their signal properties on T1- and T2-weighted imaging allow for evaluation of both intraluminal and bowel wall pathology. In specific situations such as with MR enterography, MR defecography, and accurate local staging of certain pelvic tumors, the use of an endoluminal contrast agent is imperative in providing adequate diagnostic imaging. In other clinical scenarios, the use of an endoluminal contrast agent may serve as an indispensable problem-solving tool.

AB - Magnetic resonance (MR) imaging of the abdomen and pelvis can be limited for assessment of different conditions when imaging inadequately distended hollow organs. Endoluminal contrast agents may provide improved anatomic definition and detection of subtle pathology in such scenarios. The available routes of administration for endoluminal contrast agents include oral, endorectal, endovaginal, intravesicular, and through non-physiologic accesses. Appropriate use of endoluminal contrast agents requires a thorough understanding of the clinical indications, available contrast agents, patient preparation, and interaction of the contrast agent with the desired MR imaging protocol. For example, biphasic oral enteric contrast agents are preferred in MR enterography as their signal properties on T1- and T2-weighted imaging allow for evaluation of both intraluminal and bowel wall pathology. In specific situations such as with MR enterography, MR defecography, and accurate local staging of certain pelvic tumors, the use of an endoluminal contrast agent is imperative in providing adequate diagnostic imaging. In other clinical scenarios, the use of an endoluminal contrast agent may serve as an indispensable problem-solving tool.

KW - Endoluminal contrast

KW - GI imaging

KW - GU imaging

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=84975784243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975784243&partnerID=8YFLogxK

U2 - 10.1007/s00261-016-0668-0

DO - 10.1007/s00261-016-0668-0

M3 - Review article

C2 - 26907710

AN - SCOPUS:84975784243

VL - 41

SP - 1378

EP - 1398

JO - Abdominal Radiology

JF - Abdominal Radiology

SN - 2366-004X

IS - 7

ER -